altRX vs Effecty
altRX costs $11 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Effecty
Best for: moving between compounded and brand without changing seller
Visit Effecty →If you are choosing between altRX and Effecty, the first difference is cost: altRX is $11 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Effecty leads our six-part score, 8.2 to 7.6. One of the two has an FDA warning letter on record, covered below.
altRX vs Effecty price
altRX is the cheaper way in: $149 a month against $160 a month at Effecty. That is $11 less each month (7% lower), or about $132 over a year of treatment.
Drug by drug: Semaglutide is cheaper at altRX ($149 a month vs $160 a month); tirzepatide is cheaper at Effecty ($240 a month vs $249 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format they match: each offers compounded injections and brand-name pens.
Where each one treats patients
altRX lists 50 states, and Effecty lists 50 states.
They overlap in 50 states.
Pricing
altRX
Effecty
$60 first month, then $160/mo on the 12-month plan.
$105 first month, then $205/mo.
NEW tirzepatide-class dual-agonist line. $140 first month, then $240/mo on the 12-month plan.
$205 first month, then $305/mo.
What each price covers
Both prices cover the clinician visit, the medication itself and shipping.
altRX is silent on lab work and coaching.
Effecty is silent on lab work and coaching.
altRX
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Effecty
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Effecty scores 8.2 and altRX 7.6 out of 10.
Effecty is stronger on value (6.0 vs 5.0) and trust & safety (8.5 vs 6.0).
Effectiveness, user experience, accessibility and support are within half a point.
altRX
7.6/10
Effecty
8.2/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent altRX a warning letter dated June 8, 2026 (letter 728236), and it is still open.
Effecty has no FDA warning letter on record with us.
Features & Coverage
| Feature | altRX | Effecty |
|---|---|---|
| Starting Price | ✓$149/mo | $160/mo |
| Features | ✓8 features | 7 features |
| States Available | 50 | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About altRX
Compounded plans open at $149 for semaglutide and $249 for tirzepatide. Branded medication runs $1,149-$1,579, a figure that already contains the consult and the shipping. Every one of the four FDA-approved brands is stocked, Mounjaro, Ozempic, Wegovy and Zepbound, which no other entry in our directory matches. altRX works in both modalities, holds LegitScript certification, and prints the FDA compounded-medication disclaimer.
Read our full altRX review →About Effecty
Compounded GLP-1 injections cost $160-$205/mo at Effecty, which also carries the brand-name drugs Mounjaro, Zepbound, Wegovy and Ozempic. There are no membership fees, shipping reaches all states nationwide, and the platform is LegitScript certified.
Read our full Effecty review →Pros & Cons
altRX
What we like
- Tirzepatide costs $1249 a month, close to the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Semaglutide costs $1149 a month, 15% above the $997 median for brand-name semaglutide across the sellers we compare
- The FDA has issued altRX a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Effecty
What we like
- Semaglutide costs $160 a month, 14% below the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $240 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to Effecty
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Effecty wins this one, 8.2 to 7.6, above all for moving between compounded and brand without changing seller. altRX undercuts it by $11 a month, so if the monthly bill is what decides it, altRX is the pick. altRX fits better if semaglutide from $1149/month is your priority.
Choose altRX if…
You want semaglutide from $1149/month and an opening price near $149 a month.
Choose Effecty if…
You want moving between compounded and brand without changing seller and an opening price near $160 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Trimi Health
Knowing which pharmacy fills the vial: it names VialsRx
From $99/mo
Get started →ShedRx
Oral orforglipron alongside the injectables
From $149/mo
Get started →bmiMD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →altRX vs Effecty: FAQ
Close alternatives to altRX and Effecty
- altRX vs Gala
- altRX vs Sprout Health
- altRX vs Aquivia Health
- altRX vs Vytora Health
- Effecty vs Vytora Health
- Effecty vs Gala
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.